The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes for transplant-eligible, newly diagnosed Black patients (Pts) with multiple myeloma (MM): The Levine Cancer Institute (LCI) experience.
 
Barry Paul
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Janssen Oncology
Speakers' Bureau - Amgen
 
Shebli Atrash
Honoraria - Janssen
Speakers' Bureau - Celgene; Janssen
Research Funding - Amgen; Celgene/Bristol-Myers Squibb (Inst); GlaxoSmithKline; Janssen Oncology (Inst); Karyopharm Therapeutics
 
Myra M. Robinson
No Relationships to Disclose
 
Megan Jagosky
No Relationships to Disclose
 
Manisha Bhutani
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); C4 Therapeutics (Inst); Celularity (Inst); Cerecor (Inst); Janssen Research & Development (Inst); MedImmune (Inst); Millenium Pharamceuticals (Inst)
 
Cindy Varga
Honoraria - Adaptive Biotechnologies
 
Mauricio Pineda-Roman
Consulting or Advisory Role - Novartis
 
Reed N. Friend
No Relationships to Disclose
 
David Foureau
No Relationships to Disclose
 
Kristen Cassetta
No Relationships to Disclose
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Oncopeptides; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Pfizer; Sanofi; Secura Bio
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline